HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
The purpose of this study is to test the safety and efficacy of the investigational drug called repotrectinib in children whose cancers have specific genetic changes (in the ALK, ROS1, or NTRK1-3 genes).
